rs139631202

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1

The NM_001160372.4(TRAPPC9):​c.263C>T​(p.Ser88Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000914 in 1,614,064 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00068 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00094 ( 1 hom. )

Consequence

TRAPPC9
NM_001160372.4 missense

Scores

1
7
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:9B:2

Conservation

PhyloP100: 7.89
Variant links:
Genes affected
TRAPPC9 (HGNC:30832): (trafficking protein particle complex subunit 9) This gene encodes a protein that likely plays a role in NF-kappa-B signaling. Mutations in this gene have been associated with autosomal-recessive cognitive disability. Alternatively spliced transcript variants have been described.[provided by RefSeq, Feb 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0205445).
BP6
Variant 8-140451111-G-A is Benign according to our data. Variant chr8-140451111-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 212436.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=8}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000683 (104/152234) while in subpopulation NFE AF= 0.00109 (74/68016). AF 95% confidence interval is 0.000889. There are 0 homozygotes in gnomad4. There are 56 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TRAPPC9NM_001160372.4 linkuse as main transcriptc.263C>T p.Ser88Leu missense_variant 2/23 ENST00000438773.4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TRAPPC9ENST00000438773.4 linkuse as main transcriptc.263C>T p.Ser88Leu missense_variant 2/231 NM_001160372.4 P1Q96Q05-1
TRAPPC9ENST00000648948.2 linkuse as main transcriptc.263C>T p.Ser88Leu missense_variant 2/23 P1Q96Q05-1

Frequencies

GnomAD3 genomes
AF:
0.000684
AC:
104
AN:
152118
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00207
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00109
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000676
AC:
170
AN:
251454
Hom.:
0
AF XY:
0.000625
AC XY:
85
AN XY:
135900
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00152
Gnomad NFE exome
AF:
0.00114
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000938
AC:
1371
AN:
1461830
Hom.:
1
Cov.:
80
AF XY:
0.000854
AC XY:
621
AN XY:
727212
show subpopulations
Gnomad4 AFR exome
AF:
0.0000896
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000696
Gnomad4 FIN exome
AF:
0.00193
Gnomad4 NFE exome
AF:
0.00109
Gnomad4 OTH exome
AF:
0.000695
GnomAD4 genome
AF:
0.000683
AC:
104
AN:
152234
Hom.:
0
Cov.:
31
AF XY:
0.000752
AC XY:
56
AN XY:
74446
show subpopulations
Gnomad4 AFR
AF:
0.000144
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00207
Gnomad4 NFE
AF:
0.00109
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.000945
Hom.:
0
Bravo
AF:
0.000533
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00140
AC:
12
ExAC
AF:
0.000848
AC:
103
EpiCase
AF:
0.000382
EpiControl
AF:
0.000948

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:9Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Intellectual disability, autosomal recessive 13 Uncertain:4
Uncertain significance, criteria provided, single submitterclinical testingBaylor GeneticsJul 31, 2018This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 31, 2018- -
Uncertain significance, criteria provided, single submitterresearchHudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for BiotechnologyJul 03, 2018- -
Uncertain significance, criteria provided, single submitterclinical testingRevvity Omics, RevvityApr 18, 2020- -
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitterclinical testingInvitaeJan 21, 2024- -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxFeb 19, 2021In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoJan 16, 2015- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 18, 2017The p.S186L variant (also known as c.557C>T), located in coding exon 2 of the TRAPPC9 gene, results from a C to T substitution at nucleotide position 557. The serine at codon 186 is replaced by leucine, an amino acid with dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Intellectual Disability, Recessive Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Intellectual disability Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingCentre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de LilleJan 01, 2019- -
TRAPPC9-related disorder Benign:1
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesNov 01, 2022This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.22
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.21
T;T;.;T
Eigen
Uncertain
0.44
Eigen_PC
Uncertain
0.52
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.86
.;.;D;D
M_CAP
Benign
0.0053
T
MetaRNN
Benign
0.021
T;T;T;T
MetaSVM
Benign
-0.77
T
MutationAssessor
Benign
1.4
L;L;.;L
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Uncertain
0.57
T
PROVEAN
Uncertain
-3.1
.;D;D;.
REVEL
Benign
0.15
Sift
Uncertain
0.0050
.;D;T;.
Sift4G
Uncertain
0.0070
.;D;D;.
Polyphen
0.97
D;D;P;D
Vest4
0.46, 0.43
MVP
0.39
MPC
0.46
ClinPred
0.051
T
GERP RS
5.3
Varity_R
0.21
gMVP
0.56

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139631202; hg19: chr8-141461210; COSMIC: COSV66892923; COSMIC: COSV66892923; API